Global Human Milk Oligosaccharides (HMO) Market Report By Product (2’-Fucosyllactose (2’FL), 3’-Fucosyllactose (3’FL), 3’-Sialyllactose (3’SL), 6’-Sialyllactose (6’SL), Lacto-N-tetraose (LNT), And Lacto-N-neotetraose (LNnT)), Application (Infant Formula, Functional Food & Beverages, Food Supplements, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2018-2025
ID:VMR11210620
March 2019
Report Formats:

As per this study, the Global Human Milk Oligosaccharides (HMO) Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

The human milk oligosaccharides or HMO are the complex carbohydrates mainly found in human milk. HMOs is beneficial for microbiome and enhance the immunity. HMO is basically used in the production of infant formula, functional food & beverages, and food supplements. Additionally, it helps to prevent individuals from various disease such as cardiovascular diseases, type 1 diabetes, and infectious diseases.
 
Market Dynamics
 
The increasing awareness regarding HMOs and its benefits of improving immunity and bacterial growth which are essential to human body are driving the market growth. Growing applications and product line in functional food is another factor accelerating the demand for HMOs.  Additionally, growing R&D for extraction of HMO with new techniques is also expected to boost the market growth. On the other hand, high production cost associated with HMOs and availability of substitutes such as galactooligosaccharides and fructooligosaccharides may hamper the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of human milk oligosaccharides (HMO).
 
Market Segmentation
 
The broad human milk oligosaccharides (HMO) market has been sub-grouped into product and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product

  • 2’-Fucosyllactose (2’FL)
  • 3’-Fucosyllactose (3’FL)
  • 3’-Sialyllactose (3’SL)
  • 6’-Sialyllactose (6’SL)
  • Lacto-N-tetraose (LNT)
  • Lacto-N-neotetraose (LNnT)
 
By Application
  • Infant Formula
  • Functional Food & Beverages
  • Food Supplements
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for human milk oligosaccharides (HMO) in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Human Milk Oligosaccharides (HMO) Market By Revenue (USD MN)

Europe Human Milk Oligosaccharides (HMO) Market By Revenue

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the human milk oligosaccharides (HMO) market includes Elicityl S.A., Glycom A/S , Glycosyn LLC, Inbiose NV, Jennewein Biotechnologie GmbH, Medolac Laboratories and ZuChem Inc.. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Human Milk Oligosaccharides (HMO)
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Human Milk Oligosaccharides (HMO) Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET ANALYSIS BY PRODUCT
  • Market In 2’-Fucosyllactose (2’FL)
  • Market In 3’-Fucosyllactose (3’FL)
  • Market In 3’-Sialyllactose (3’SL)
  • Market In 6’-Sialyllactose (6’SL)
  • Market In Lacto-N-tetraose (LNT)
  • Market In Lacto-N-neotetraose (LNnT)
 
5. HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET ANALYSIS BY APPLICATION
  • Market In Infant Formula
  • Market In Functional Food & Beverages
  • Market In Food Supplements
  • Market In Others
 
6. HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE HUMAN MILK OLIGOSACCHARIDES (HMO) COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE HUMAN MILK OLIGOSACCHARIDES (HMO) INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Elicityl S.A.
  • Glycom A/S
  • Glycosyn LLC
  • Inbiose NV
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • ZuChem Inc.
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Human Milk Oligosaccharides (HMO)
Table 2.  Global Human Milk Oligosaccharides (HMO) Market By Product
Table 3.  Global Human Milk Oligosaccharides (HMO) Market By Application
Table 4.  Global Human Milk Oligosaccharides (HMO) Market By Geography
Table 5.  North America Human Milk Oligosaccharides (HMO) Market
Table 6.  Europe Human Milk Oligosaccharides (HMO) Market
Table 7.  Asia Pacific Human Milk Oligosaccharides (Hmo) Market
Table 8.  Latin America Human Milk Oligosaccharides (HMO) Market
Table 9.  Middle East And Africa Human Milk Oligosaccharides (HMO) Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Human Milk Oligosaccharides (HMO) Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Human Milk Oligosaccharides (HMO)
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Human Milk Oligosaccharides (HMO) Market By Product
Fig. 8.     Global Human Milk Oligosaccharides (HMO) Market By Application
Fig. 9.     Global Human Milk Oligosaccharides (HMO) Market By Geography
Fig. 10.   North America Human Milk Oligosaccharides (HMO) Market
Fig. 11.   Europe Human Milk Oligosaccharides (HMO) Market
Fig. 12.   Asia Pacific Human Milk Oligosaccharides (HMO) Market
Fig. 13.   Latin America Human Milk Oligosaccharides (HMO) Market
Fig. 14.   Middle East And Africa Human Milk Oligosaccharides (HMO) Market
Fig. 15.   Market Share Of Human Milk Oligosaccharides (HMO) Companies
Fig. 16.   Recent Developments In Human Milk Oligosaccharides (HMO) Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials